MyMD Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Equity - Schedule of Proceeds From Initial Public Offering (Details)

Equity - Schedule of Proceeds From Initial Public Offering (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Gross Proceeds:	$ 14,998,500
Payments of Stock Issuance Costs	1,897,164us-gaap_PaymentsOfStockIssuanceCosts	55,708us-gaap_PaymentsOfStockIssuanceCosts
Net Proceeds:	13,101,336
Underwriter And Aegis Expenses [Member]
Payments of Stock Issuance Costs	1,344,055
Underwriter And Aegis Expenses [Member] \| Underwriter Commission [Member]
Payments of Stock Issuance Costs	1,049,895
Underwriter And Aegis Expenses [Member] \| Underwriter Expenses [Member]
Payments of Stock Issuance Costs	149,985
Underwriter And Aegis Expenses [Member] \| Aegis Legal Fees [Member]
Payments of Stock Issuance Costs	80,000
Underwriter And Aegis Expenses [Member] \| Aegis Registration Expenses [Member]
Payments of Stock Issuance Costs	7,500
Underwriter And Aegis Expenses [Member] \| Aegis Miscellaneous Expenses [Member]
Payments of Stock Issuance Costs	36,675
Underwriter And Aegis Expenses [Member] \| Aegis Road Show Expenses [Member]
Payments of Stock Issuance Costs	20,000
Akers Biosciences Expenses [Member]
Payments of Stock Issuance Costs	553,109
Akers Biosciences Expenses [Member] \| Legal Accounting Expenses [Member]
Payments of Stock Issuance Costs	393,298
Akers Biosciences Expenses [Member] \| Printing Document Prep [Member]
Payments of Stock Issuance Costs	62,101
Akers Biosciences Expenses [Member] \| Registration Expenses [Member]
Payments of Stock Issuance Costs	55,946
Akers Biosciences Expenses [Member] \| Road Show Expenses [Member]
Payments of Stock Issuance Costs	$ 41,764